Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

The Journal of Urology
Donna P AnkerstIan M Thompson

Abstract

The online Prostate Cancer Prevention Trial risk calculator combines prostate specific antigen, digital rectal examination, family and biopsy history, age and race to determine the risk of prostate cancer. In this report we incorporate the biomarker prostate cancer gene 3 into the Prostate Cancer Prevention Trial risk calculator. Methodology was developed to incorporate new markers for prostate cancer into the Prostate Cancer Prevention Trial risk calculator based on likelihood ratios calculated from separate case control or cohort studies. The methodology was applied to incorporate the marker prostate cancer gene 3 into the risk calculator based on a cohort of 521 men who underwent prostate biopsy with measurements of urinary prostate cancer gene 3, serum prostate specific antigen, digital rectal examination and biopsy history. External validation of the updated risk calculator was performed on a cohort of 443 European patients, and compared to Prostate Cancer Prevention Trial risks, prostate specific antigen and prostate cancer gene 3 by area underneath the receiver operating characteristic curve, sensitivity and specificity. The AUC of posterior risks (AUC 0.696, 95% CI 0.641-0.750) was higher than that of prostate specific ...Continue Reading

References

Jun 26, 2003·The New England Journal of Medicine·Ian M ThompsonCharles A Coltman
May 28, 2004·The New England Journal of Medicine·Ian M ThompsonCharles A Coltman
Jul 7, 2005·JAMA : the Journal of the American Medical Association·Ian M ThompsonCharles A Coltman
Apr 20, 2006·Journal of the National Cancer Institute·Ian M ThompsonCharles A Coltman
Sep 7, 2006·Journal of the National Cancer Institute·William E BarlowKarla Kerlikowske
Dec 22, 2006·The New England Journal of Medicine·Thomas J WangRamachandran S Vasan
Jan 16, 2007·The Journal of Urology·Felix K-H ChunPierre I Karakiewicz
Jul 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ian M ThompsonCharles A Coltman
Feb 26, 2008·The Journal of Urology·Ina L DerasJack Groskopf

❮ Previous
Next ❯

Citations

Oct 29, 2010·Current Oncology Reports·Elise D Cook, Ana C Nelson
Mar 28, 2013·Current Urology Reports·Allison S GlassMatthew R Cooperberg
Mar 19, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xavier FilellaWladimiro Jiménez
Dec 19, 2012·Nature Reviews. Urology·Monique J Roobol, Sigrid V Carlsson
Nov 2, 2011·Prostate Cancer and Prostatic Diseases·A K WuK Shinohara
Sep 3, 2013·International Journal of Molecular Sciences·Alain RuffionVirginie Vlaeminck-Guillem
Sep 28, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·UNKNOWN Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Nov 2, 2013·Clinical Biochemistry·S DijkstraJ A Schalken
Feb 6, 2014·Urologic Oncology·Javier Romero OteroKarim A Touijer
Apr 24, 2013·The Journal of Urology·David J Hernandez
Jul 4, 2012·European Urology·Matthew R Cooperberg
Feb 7, 2012·Urologic Oncology·Yuanyuan LiangHector R Camarena-Reynoso
Jan 17, 2012·The Journal of Urology·Maciej Salagierski, Jack A Schalken
Oct 29, 2011·Critical Reviews in Oncology/hematology·Chris H Bangma, Monique J Roobol
Aug 30, 2011·European Urology·Marco AuprichHenk van der Poel
Nov 26, 2010·Cancer Letters·John R DayHarry Rittenhouse
Sep 8, 2010·Urologic Oncology·Christopher L AmlingEric A Klein
Oct 14, 2009·Seminars in Thoracic and Cardiovascular Surgery·Raphael Bueno
Nov 29, 2015·The Urologic Clinics of North America·Jeffrey J TosoianChristian P Pavlovich
Jun 27, 2015·Asian Journal of Andrology·Igor Sorokin, Badar M Mian
Jun 23, 2009·Cancer·Michael P HermanAshutosh Tewari
Dec 24, 2011·BJU International·Roger Kirby, John M Fitzpatrick
Nov 19, 2011·Biometrical Journal. Biometrische Zeitschrift·Donna P AnkerstIan M Thompson
May 13, 2014·Internal Medicine Journal·C PezaroI D Davis
Nov 26, 2009·BJU International·David SchillingArnulf Stenzl
Sep 12, 2015·Future Oncology·Carsten StephanBernhard Ralla
Sep 13, 2015·BMC Cancer·Jose Rubio-BrionesJose A Lopez-Guerrero
Apr 15, 2014·Biochimica Et Biophysica Acta·Carsten StephanKlaus Jung
Nov 19, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K S LouieP Sasieni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.